Gabsang Lee
Overview
Explore the profile of Gabsang Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
3937
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Du J, Zhen G, Chen H, Zhang S, Qing L, Yang X, et al.
Biomaterials
. 2025 Feb;
318:123172.
PMID: 39986974
No abstract available.
2.
Marcella B, Hockey B, Braun J, Whitley K, Geromella M, Baranowski R, et al.
Nat Commun
. 2024 Nov;
15(1):10210.
PMID: 39587049
Inhibiting glycogen synthase kinase 3 (GSK3) improves muscle function, metabolism, and bone health in many diseases and conditions; however, whether GSK3 should be targeted for Duchenne muscular dystrophy (DMD), a...
3.
Choi H, Oh D, Kim M, Jawad A, Zheng H, Cai L, et al.
Stem Cell Res Ther
. 2024 Aug;
15(1):245.
PMID: 39113095
Background: The establishment of stable porcine embryonic stem cells (pESCs) can contribute to basic and biomedical research, including comparative developmental biology, as well as assessing the safety of stem cell-based...
4.
Moss K, Mi R, Kawaguchi R, Ehmsen J, Shi Q, Vargas P, et al.
iScience
. 2024 May;
27(6):109855.
PMID: 38770143
Establishing robust models of human myelinating Schwann cells is critical for studying peripheral nerve injury and disease. Stem cell differentiation has emerged as a key human cell model and disease...
5.
Kim M, Yoon S, Choi J, Kim Y, Lee G
Int J Stem Cells
. 2024 Mar;
18(1):21-36.
PMID: 38449089
Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of midbrain dopaminergic neurons, leading to motor symptoms. While current treatments provide limited relief, they don't alter disease progression....
6.
Kim M, Kim H, Lee G
Adv Healthc Mater
. 2024 Jan;
13(21):e2303041.
PMID: 38269602
Parkinson's disease (PD) is one of the most devastating neurological diseases; however, there is no effective cure yet. The availability of human induced pluripotent stem cells (iPSCs) provides unprecedented opportunities...
7.
Kc E, Islam J, Lee G, Park Y
Mol Neurobiol
. 2023 Sep;
61(3):1769-1780.
PMID: 37775720
The integration of optogenetics in the trigeminal pain circuitry broadens and reinforces existing pain investigations. Similar to research on spinal neuropathic pain, the exploration of the underlying determinants of orofacial...
8.
Ra E, Kim M, Lee G
STAR Protoc
. 2023 Sep;
4(4):102609.
PMID: 37742181
Alpha-synuclein (α-syn) aggregation is a principal factor in Parkinson's disease (PD) onset. Here, we present a protocol for optogenetic induction of α-syn aggregation in human midbrain dopaminergic (mDA) neurons, facilitating...
9.
Kim M, Ra E, Kweon S, Seo B, Ko H, Oh Y, et al.
Cell Stem Cell
. 2023 Jun;
30(7):973-986.e11.
PMID: 37339636
Human induced pluripotent stem cells (hiPSCs) offer advantages for disease modeling and drug discovery. However, recreating innate cellular pathologies, particularly in late-onset neurodegenerative diseases with accumulated protein aggregates including Parkinson's...
10.
Fasano C, Chambers S, Lee G, Tomishima M, Studer L
Cell Stem Cell
. 2023 Jun;
30(6):905.
PMID: 37267920
No abstract available.